TipRanks
Advertisement
Advertisement

JP:4875 Stock Latest News

MediciNova Extends Office Lease, Signals Long-Term Stability
Company AnnouncementsMediciNova Extends Office Lease, Signals Long-Term Stability
21h ago
8K
MNOV
MediciNova reports results from MN-001-NATG-202 Phase 2 trial of MN-001
PremiumThe Fly
MediciNova reports results from MN-001-NATG-202 Phase 2 trial of MN-001
1d ago
MNOV
Buy Rating Reaffirmed on MediciNova as Advancing Pipeline and Upcoming Catalysts Support Unchanged $6 Price Target
PremiumRatings
Buy Rating Reaffirmed on MediciNova as Advancing Pipeline and Upcoming Catalysts Support Unchanged $6 Price Target
4d ago
MNOV
Analyst Reiterates Buy on Medicinova, Maintaining $10 Price Target Amid Advancing ALS and Metabolic Disease Programs
PremiumRatings
Analyst Reiterates Buy on Medicinova, Maintaining $10 Price Target Amid Advancing ALS and Metabolic Disease Programs
5d ago
MNOV
MediciNova completes LPLV in Phase 2b/3 clinical trial evaluating MN-166
PremiumThe Fly
MediciNova completes LPLV in Phase 2b/3 clinical trial evaluating MN-166
5d ago
MNOV
MediciNova initiated with a Buy at Roth Capital
PremiumThe FlyMediciNova initiated with a Buy at Roth Capital
12d ago
MNOV
MediciNova Ends Standby Equity Financing Agreement
Premium
Company Announcements
MediciNova Ends Standby Equity Financing Agreement
27d ago
8K
MNOV
MediciNova Updates Executive Contracts, Enhancing Change-in-Control Protection
Premium
Company Announcements
MediciNova Updates Executive Contracts, Enhancing Change-in-Control Protection
1M ago
8K
MNOV
Jason McCarthy Reiterates Buy on MediciNova, Maintains $6 Price Target Ahead of Key ALS and Metabolic Disease Readouts
PremiumRatings
Jason McCarthy Reiterates Buy on MediciNova, Maintains $6 Price Target Ahead of Key ALS and Metabolic Disease Readouts
2M ago
MNOV
Analyst Reiterates Buy on MediciNova with Unchanged $10 Price Target Amid Progress of Lead Clinical Programs
PremiumRatings
Analyst Reiterates Buy on MediciNova with Unchanged $10 Price Target Amid Progress of Lead Clinical Programs
2M ago
MNOV
MediciNova: Differentiated NAFLD/MASH Profile and Complementary APOC3 Positioning Support Unchanged $6 Target and Buy Rating
PremiumRatings
MediciNova: Differentiated NAFLD/MASH Profile and Complementary APOC3 Positioning Support Unchanged $6 Target and Buy Rating
2M ago
MNOV
Roth Capital biopharmaceuticals analyst holds a webinar
PremiumThe Fly
Roth Capital biopharmaceuticals analyst holds a webinar
3M ago
BIIB
COYA
Analyst Reiterates Buy on MediciNova as Advancing Pipeline and Upcoming ALS Catalysts Support Unchanged $6 Price Target
PremiumRatingsAnalyst Reiterates Buy on MediciNova as Advancing Pipeline and Upcoming ALS Catalysts Support Unchanged $6 Price Target
3M ago
MNOV
MediciNova Shareholders Reject Proposal to Increase Authorized Stock
Premium
Company Announcements
MediciNova Shareholders Reject Proposal to Increase Authorized Stock
3M ago
8K
MNOV
Analyst Initiates Buy on MediciNova, Citing Pivotal Tipelukast and Ibudilast Catalysts to Support $10 Price Target
Premium
Ratings
Analyst Initiates Buy on MediciNova, Citing Pivotal Tipelukast and Ibudilast Catalysts to Support $10 Price Target
4M ago
MNOV
Medicinova: Buy Rating Reiterated as Pipeline Advances and Cash Runway Extends, $6 Price Target Maintained
PremiumRatings
Medicinova: Buy Rating Reiterated as Pipeline Advances and Cash Runway Extends, $6 Price Target Maintained
4M ago
MNOV
MediciNova’s peer-reviewed ibudilast study advances clinical translation
PremiumThe Fly
MediciNova’s peer-reviewed ibudilast study advances clinical translation
5M ago
MNOV
Super Micro downgraded, MongoDB upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Super Micro downgraded, MongoDB upgraded: Wall Street’s top analyst calls
6M ago
BIP
BOX
Maxim resumes MediciNova at Buy on potential value-driving data events this year
PremiumThe Fly
Maxim resumes MediciNova at Buy on potential value-driving data events this year
6M ago
MNOV
MediciNova resumed with a Buy at Maxim
PremiumThe FlyMediciNova resumed with a Buy at Maxim
6M ago
MNOV
MediciNova initiated with a Buy at H.C. Wainwright
Premium
The Fly
MediciNova initiated with a Buy at H.C. Wainwright
7M ago
MNOV
MediciNova management to meet with Maxim
Premium
The Fly
MediciNova management to meet with Maxim
7M ago
MNOV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >